COOPER COMPANIES, INC. News
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
see moreCOOPER COMPANIES, INC. Market News
14h
Investor Alerts Mount as CooperCompanies Faces Securities Fraud Investigations
- Within the past week, CooperCompanies (NASDAQ: COO) has become subject to multiple securities fraud and shareholder lawsuits, prompting heightened scrutiny and investor alerts.
14d
CooperCompanies Accelerates Vision Care Innovation with Southampton “Vision Centre” Opening
CooperCompanies (COO) unveiled a new R&D hub, The Vision Centre in Southampton, with six accelerated product launches, reinforcing its vision‑care leadership.
28d
CooperCompanies Wraps Up Strategic Review, Boosts Buyback and Eyes Innovation with New R&D Hub
CooperCompanies ended its strategic review, opted to retain CooperSurgical, expanded buyback to $3 billion, and unveiled plans for a new global R&D hub for CooperVision.
28 Aug at 07:51
CooperCompanies’ Sustainability Push Gains Traction With First-Time Scope 3 Emissions Disclosure
CooperCompanies (COO) this week published its 2025 sustainability report, for the first time disclosing Scope 3 emissions—a move adding transparency across its CooperVision and CooperSurgical divisions.
14 Aug at 07:52
Cooper Companies Reports Significant Revenue Growth in Q2 2026 Amid Strategic Acquisitions
San Ramon, CA — August 13, 2026 — The Cooper Companies, Inc. (NYSE: COO), a global leader in medical devices, reported robust financial results for the second quarter of fiscal year 2026, alongside strategic initiatives that have influenced its stock performance.